Refresh

AstraZeneca Pharma India Ltd. - Research Center

506820 ASTRAZEN Group (A) BSE data
Back to Company

Results

Statement

More

Quarterly results in brief
(Rs crore)
Mar' 24 Dec' 23 Sep' 23 Jun' 23 Mar' 23

Sales

383.20 305.79 311.07 295.47 284.70

Operating profit

49.39 15.06 52.76 67.25 59.85

Interest

-0.07 0.61 0.50 0.15 0.09

Gross profit

58.12 24.10 60.63 75.20 67.76

EPS (Rs)

15.79 6.32 20.95 21.54 6.91
Quarterly  results in details
Mar' 24 Dec' 23 Sep' 23 Jun' 23 Mar' 23

Other income

8.66 9.66 8.37 8.10 8.00

Stock adjustment

104.95 -70.76 -56.62 -11.34 -26.70

Raw material

33.62 37.52 38.80 19.08 21.62

Power and fuel

- - - - -

Employee expenses

57.98 63.23 65.27 54.97 66.86

Excise

- - - - -

Admin and selling expenses

- - - - -

Research and development expenses

- - - - -

Expenses capitalised

- - - - -

Other expenses

137.26 260.74 210.86 165.51 163.08

Provisions made

- - - - -

Depreciation

3.76 3.70 3.67 3.80 4.25

Taxation

14.88 4.60 21.01 17.54 6.01

Net profit / loss

39.48 15.80 52.37 53.86 17.27

Extra ordinary item

- - 16.43 - -40.23

Prior year adjustments

- - - - -

Equity capital

5.00 5.00 5.00 5.00 5.00

Equity dividend rate

- - - - -

Agg.of non-prom. shares (Lacs)

- - - - -

Agg.of non promotoholding (%)

- - - - -

OPM (%)

12.89 4.92 16.96 22.76 21.02

GPM (%)

14.83 7.64 18.98 24.77 23.15

NPM (%)

10.07 5.01 16.39 17.74 5.90
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com